UNSPSC 85813818: Introduction of other antineoplastic into bone marrow, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into bone marrow, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0A305

UNSPSC 85813818 Introduction of other antineoplastic into bone marrow, percutaneous approach is a Commodity code with little relevant recent activity aligned to its stated clinical scope. The recent state and local opportunities tagged to this code span telehealth urgent care, occupational health screening, cancer registry services, retinal imaging devices, EMS staffing, employee health clinics, jail medical services, psychological evaluations, wellness platforms, and opioid treatment programs—none of which involve percutaneous bone marrow antineoplastic therapy or related oncology procedures. The mismatch between the UNSPSC code's nominal scope and the work actually being procured suggests this code does not describe the health and medical services state and local governments are actively buying at present.

The issuing bodies in the recent-opportunities block span county health systems (Santa Clara, San Mateo, Brevard), municipal health departments (Phoenix, Ocala, Atlanta), state agencies (Colorado Department of Human Services, Texas Health and Human Services Commission, Nevada Health Authority), and special districts (Inland Empire Health Plan, Events DC). Geographic spread includes California, Georgia, Nevada, Colorado, Texas, Florida, Arizona, New Mexico, Oregon, Illinois, Kansas, New York, and the District of Columbia. Representative recent solicitations include Inland Empire Health Plan's RFI for 24/7 virtual urgent care services (due October 31, 2026); San Mateo County's RFP for cancer registry services (due October 12, 2026); Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (due December 10, 2026); and Colorado Department of Human Services' RFP for nursing home placement beds with enhanced psychiatric services (due September 10, 2026). None of these opportunities align with antineoplastic bone marrow therapy or percutaneous oncology procedures. Business development professionals should skip this code unless pursuing opportunities in general health services procurement, not cancer therapy delivery.